Board Comments on Misguided Campaign from Mina Sooch to Replace a Majority of Opus’ Directors and Promote a Flawed StrategyUrges Stockholders to ...

RESEARCH TRIANGLE PARK, N.C., April 07, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (“Opus ... marks a pivotal point in the Company’s transformation and will establish our foundation ...

Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited ...

Not everyone grieves genetic loss. This piece explores the complex, personal journey of donor conception—and why your ...

Opus Genetics Inc. (“Legacy Opus”), then ... along with six others who have been instrumental in driving the Company's transformation over the last two years, for election to the Board.

Horizontal gene transfer (HGT) is the movement of genetic material from one organism to another. In this article, we will ...

Provides update on the Company's transformation and promising portfolio of innovative gene therapy treatments for inherited retinal diseases Strong cash position with $21.5 million financing to supple ...

Scientists say they have found a pattern of so-called epigenetic 'marks' in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may keep at least a ...